Clin Osteol 2017; 22(1): 32-37

Vitamin K and its importance for the vessel wall and bone metabolismReview articles

M. Laburda, K. Vondra, V. Zamrazil, J. Čepová, E. Klapková, K. Dunovská

Keywords: vitamín K, y-karboxylace, calcification paradox, podkarboxylovaný osteokalcin, osteoporóza, SUMMARY

Published: June 11, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Laburda M, Vondra K, Zamrazil V, Čepová J, Klapková E, Dunovská K. Vitamin K and its importance for the vessel wall and bone metabolism. Osteologický bulletin. 2017;22(1):32-37.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Brody T. Nutritional Biochemistry. 2nd ed. San Diego, Academic Press 1999; p 1006.
    2. Willems BA, Vermeer C, Reutelingsperger CP, Schurgers LJ. The realm of vitamin K dependent proteins: shifting from coagulation toward cal­ cification. Mol Nutr Food Res 2014;58:1620-1635. Go to original source...
    3. Beulens JW, Booth SL, van den Heuvel EG, Stoecklin E, Baka A, Vermeer C. The role of menaquinones (vitamin K2) in human health. Br J Nutr 2013;110:1357-1368. Go to original source...
    4. Štěpán J. Význam vitamínu K2 pro kvalitu kosti a pro kalcifikované tkáně. PraktLék 2005;85:326-330.
    5. Iwamoto J. Vitamin K therapy for postmenopausal osteoporosis. Nutrients 2014;6:1971-1980. Go to original source...
    6. Vermeer C, Knapen MH, Schurgers LJ. Vitamin K and metabolic bo­ ne disease. J Clin Pathol 1998;51:424-426. Go to original source...
    7. Cheung AM, Tile L, Lee Y, Tomlinson G, Hawker G, Scher J, Hu H, Vieth R, Thompson L, Jamal S, Josse R. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial. PLoS Med 2008;5:e196. Erratum in: PLoS Med 2008;5:e247. Go to original source...
    8. Theuwissen E, Teunissen KJ, Spronk HM, Hamulyák K, Ten Cate H, Shearer MJ, Vermeer C, Schurgers LJ. Effect of low-dose supplements of menaquinone-7 (vitamin K2) on the stability of oralanticoagulant treatment: dose-response relationship in healthy volunteers. J Thromb Haemost 2013;11:1085-1092. Go to original source...
    9. Nakagawa K, Hirota Y, Sawada N, Yuge N, Watanabe M, Uchino Y, Okuda N, Shimomura Y, Suhara Y, Okano T. Identification of UBIAD1 as a novel human menaquinone-4 biosynthetic enzyme. Nature 2010; 468:117-121. Go to original source...
    10. Zima T et al. Laboratorní diagnostika. 2. vyd. Praha, Galén, Karo­ linum, 2007; p 906.
    11. Viegas CS, Rafael MS, Enriquez JL, Teixeira A, Vitorino R, Luís IM, Costa RM, Santos S, Cavaco S, Neves J, Macedo AL, Willems BA, Vermeer C, Simes DC. Gla-rich protein acts as a calcification inhibitor in the human cardiovascular system. Arterioscler Thromb Vasc Biol 2015;35:399-408. Go to original source...
    12. Dalmeijer GW, van der Schouw YT, Vermeer C, Magdeleyns EJ, Schurgers LJ, Beulens JW. Circulating matrix Gla protein is associated with coronary artery calcification and vitamin K status in healthy wo­ men. J Nutr Biochem 2013;24:624-628. Go to original source...
    13. Mayer O Jr, Seidlerová J, Bruthans J, Filipovský J, Timoracká K, Vaněk J, Cerná L, Wohlfahrt P, Cífková R, Theuwissen E, Vermeer C. Desphospho-uncarboxylated matrix Gla-protein is associated with mortality risk in patients with chronic stable vascular disease. Atherosclerosis 2014;235:162-168. Go to original source...
    14. Van den Heuvel EG, van Schoor NM, Lips P, Magdeleyns EJ, Deeg DJ, Vermeer C, den Heijer M. Circulating uncarboxylated matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease. Maturitas 2014;77:137-141. Go to original source...
    15. Dalmeijer GW, van der Schouw YT, Magdeleyns EJ, Vermeer C, Elias SG, Velthuis BK, de Jong PA, Beulens JW. Circulating species of ma­ trix Gla protein and the risk of vascular calcification in healthy women. Int J Cardiol 2013;168:e168-170. Go to original source...
    16. Theuwissen E, Smit E, Vermeer C. The role of vitamin K in soft-tissue calcification. Adv Nutr 2012;3:166-173. Go to original source...
    17. Flore R, Ponziani FR, Di Rienzo TA, Zocco MA, Flex A, Gerardino L, Lupascu A, Santoro L, Santoliquido A, Di Stasio E, Chierici E, Lanti A, Tondi P, Gasbarrini A Something more to say about calcium homeostasis: the role of vitamin K2 in vascular calcification and osteo­ porosis. Eur Rev Med Pharmacol Sci 2013;17:2433-2440.
    18. Kurabayashi M. Bone metabolism and cardiovascular function Update. Vascular calcification as a manifestation of bone-vascular axis. Clin Calcium 2014;24:11-19.
    19. Food and Nutrition Board, Institute of Medicine. Vitamin K. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, D. C., National Academy Press 2001; pp.162-196.
    20. Shearer MJ. Vitamin K. Lancet 1995;345:229-234. Go to original source...
    21. SELF Nutrition Data: Food Facts, Information & Calorie Calculator. http://nutritiondata.self.com
    22. Guralp O, Erel CT. Effects of vitamin K in postmenopausal women: mini review. Maturitas 2014;77:294-299. Go to original source...
    23. Schurgers LJ, Vermeer C. Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating vitamin K con­ centrations. Haemostasis 2000;30:298-307. Go to original source...
    24. Broulík P. Výživa a její vztah ke kostnímu metabolismu. Interní Med 2009;11:11-14.
    25. Žofková I. Význam vitamínu K pro kostní metabolismus. Osteologický bulletin 2007;12:49-51.
    26. Olson RE. Vitamin K. In: Shils M, Olson JA, Shike M, Ross AC. Modern Nutrition in Health and Disease. 9th ed. Baltimore, Williams & Wilkins 1999; pp.363-380.
    27. Booth SL, Golly I, Sacheck JM et al. Effect of vitamin E supplemen­ tation on vitamin K status in adults with normal coagulation status. Am J Clin Nutr 2004;80:143-148. Go to original source...
    28. Horáková E, Eliášová J. Strava při antikoagulační léčbě a diabetes mellitus. Med praxi 2012;9:134-136.
    29. Sato T, Schurgers LJ, Uenishi K. Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women. Nutr J 2012;11:1-4. Go to original source...
    30. Schurgers LJ, Teunissen KJ, Hamulyák K, Knapen MH, Vik H, Vermeer C. Vitamin K -containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood 2007; 109:3279-3283. Go to original source...
    31. Thorp JA, Gaston L, Caspers DR, Pal ML. Current concepts and con­ troversies in the use of vitamin K. Drugs 1995;49:376-387. Go to original source...
    32. Racek J. Klinická biochemie. 2. vyd. Praha, Galén, Karolinum 2006; p 329.
    33. Slíva J. Vitamín K u žen v postmenopauzálním období. Klimakterická medicína 2012;17:5-8.
    34. Kaneki M, Hedges SJ, Hosoi T, Fujiwara S, Lyons A, Crean J, Ishida N, Nakagawa M, Takechi M, Sano Y, Mizuno Y, Hoshino S, Miyao M, Inoue S, Horiki K, Shiraki M, Ouchi Y, Orimo H. Japanese Fermented Soybean Food as the Major Determinant of the Large Geographic Difference in Circulating Levels of Vitamin K2: Possible Implications for Hip-Fracture Risk. Nutrition 2001;17:315-321. Go to original source...
    35. Yonemura K, Kimura M, Miyaji T, Hishida A. Short-term effect of vi­ tamin K administration on prednisolone-induced loss of bone mineral density in patients with chronic glomerulonephritis. Calcif Tissue Int 2000;66:123-128. Go to original source...
    36. Knapen MH, Drummen NE, Smit E, Vermeer C, Theuwissen E. Threeyear low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int 2013;24: 2499-2507. Go to original source...
    37. Huang ZB, Wan SL, Lu YJ, Ning L, Liu C, Fan SW. Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postme­ nopausal women: a meta-analysis of randomized controlled trials. Osteoporos Int 2015;26:1175-1186. Go to original source...
    38. Hamidi MS, Gajic-Veljanoski O, Cheung AM. Vitamin K and bone he­ alth. J Clin Densitom 2013;16:409-413. Go to original source...
    39. Hamidi MS, Cheung AM. Vitamin K and musculoskeletal health in postmenopausal women. Mol Nutr Food Res 2014;58:1647-1657. Go to original source...
    40. Noori A, Lashkari M, Oveisi S, Khair Khah MR, Zargar A Assessment of vitamin K2 levels in osteoporotic patients: a case control study. Glob J Health Sci 2014;6:82-87. Go to original source...

    Return to the content


    Clinical Osteology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.